Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2

Naoko Asano-Kato, Kazumi Fukagawa, Naoko Okada, Murat Dogru, Kazuo Tsubota, Hiroshi Fujishima

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

PURPOSE. Tryptase that is released by mast cell degranulation has recently been thought to play a key role in wound healing in allergic bronchitis. Conjunctival fibroblasts secrete mediators and extracellular matrices that could exacerbate inflammation and papillary formation in allergic conjunctivitis. This study was conducted to investigate the effect of tryptase on the proliferation of conjunctival fibroblasts and studied whether this effect was mediated by protease-activated receptor (PAR)-2. METHODS. Conjunctival fibroblasts were cultured with or without tryptase (0.1 ng/mL to 1.0 μg/mL), and the proliferation rate was assessed after 48 hours. The effects of tryptase inhibitors (leupeptin, benzamidine) and a PAR-2 agonist (SLIGKV) were examined. The existence of PAR-2 mRNA and protein in conjunctival fibroblasts was examined by RT-PCR and Western blot analysis, respectively. The existence of PAR-2 in cultured conjunctival fibroblasts and conjunctival papillae from patients with vernal keratoconjunctivitis, as well as conjunctival tissue from normal subjects was examined by immunohistochemistry. RESULTS. Conjunctival fibroblast proliferation was upregulated by tryptase in a dose-dependent manner (P < 0.001). Leupeptin and benzamidine inhibited tryptase-induced fibroblast proliferation (P < 0.05), and SLIGKV mimicked tryptase's effect. PAR-2 mRNA and protein were detected in cultured conjunctival fibroblasts using RT-PCR and Western blot analysis. PAR-2 immunoreactivity in both the cultured conjunctival fibroblasts and in stromal cells in excised conjunctival tissues was observed. CONCLUSIONS. Tryptase increased conjunctival fibroblast proliferation and this response appeared to be mediated by PAR-2. Mast cells are the most likely source of tryptase in the conjunctiva and may play an important role in chronic exacerbations with conjunctival papillary formation in allergic conjunctivitis.

Original languageEnglish
Pages (from-to)4622-4626
Number of pages5
JournalInvestigative Ophthalmology and Visual Science
Volume46
Issue number12
DOIs
Publication statusPublished - 2005 Dec

Fingerprint

PAR-2 Receptor
Tryptases
Human Activities
Fibroblasts
seryl-leucyl-isoleucyl--glycyl-lysyl-valine
Allergic Conjunctivitis
Mast Cells
Western Blotting
Cell Degranulation
Polymerase Chain Reaction
Messenger RNA
Bronchitis
Conjunctiva
Stromal Cells
Wound Healing
Extracellular Matrix
Proteins
Immunohistochemistry

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. / Asano-Kato, Naoko; Fukagawa, Kazumi; Okada, Naoko; Dogru, Murat; Tsubota, Kazuo; Fujishima, Hiroshi.

In: Investigative Ophthalmology and Visual Science, Vol. 46, No. 12, 12.2005, p. 4622-4626.

Research output: Contribution to journalArticle

Asano-Kato, Naoko ; Fukagawa, Kazumi ; Okada, Naoko ; Dogru, Murat ; Tsubota, Kazuo ; Fujishima, Hiroshi. / Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. In: Investigative Ophthalmology and Visual Science. 2005 ; Vol. 46, No. 12. pp. 4622-4626.
@article{152f85191ed44fb69efb4bcb33fce81c,
title = "Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2",
abstract = "PURPOSE. Tryptase that is released by mast cell degranulation has recently been thought to play a key role in wound healing in allergic bronchitis. Conjunctival fibroblasts secrete mediators and extracellular matrices that could exacerbate inflammation and papillary formation in allergic conjunctivitis. This study was conducted to investigate the effect of tryptase on the proliferation of conjunctival fibroblasts and studied whether this effect was mediated by protease-activated receptor (PAR)-2. METHODS. Conjunctival fibroblasts were cultured with or without tryptase (0.1 ng/mL to 1.0 μg/mL), and the proliferation rate was assessed after 48 hours. The effects of tryptase inhibitors (leupeptin, benzamidine) and a PAR-2 agonist (SLIGKV) were examined. The existence of PAR-2 mRNA and protein in conjunctival fibroblasts was examined by RT-PCR and Western blot analysis, respectively. The existence of PAR-2 in cultured conjunctival fibroblasts and conjunctival papillae from patients with vernal keratoconjunctivitis, as well as conjunctival tissue from normal subjects was examined by immunohistochemistry. RESULTS. Conjunctival fibroblast proliferation was upregulated by tryptase in a dose-dependent manner (P < 0.001). Leupeptin and benzamidine inhibited tryptase-induced fibroblast proliferation (P < 0.05), and SLIGKV mimicked tryptase's effect. PAR-2 mRNA and protein were detected in cultured conjunctival fibroblasts using RT-PCR and Western blot analysis. PAR-2 immunoreactivity in both the cultured conjunctival fibroblasts and in stromal cells in excised conjunctival tissues was observed. CONCLUSIONS. Tryptase increased conjunctival fibroblast proliferation and this response appeared to be mediated by PAR-2. Mast cells are the most likely source of tryptase in the conjunctiva and may play an important role in chronic exacerbations with conjunctival papillary formation in allergic conjunctivitis.",
author = "Naoko Asano-Kato and Kazumi Fukagawa and Naoko Okada and Murat Dogru and Kazuo Tsubota and Hiroshi Fujishima",
year = "2005",
month = "12",
doi = "10.1167/iovs.05-0388",
language = "English",
volume = "46",
pages = "4622--4626",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "12",

}

TY - JOUR

T1 - Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2

AU - Asano-Kato, Naoko

AU - Fukagawa, Kazumi

AU - Okada, Naoko

AU - Dogru, Murat

AU - Tsubota, Kazuo

AU - Fujishima, Hiroshi

PY - 2005/12

Y1 - 2005/12

N2 - PURPOSE. Tryptase that is released by mast cell degranulation has recently been thought to play a key role in wound healing in allergic bronchitis. Conjunctival fibroblasts secrete mediators and extracellular matrices that could exacerbate inflammation and papillary formation in allergic conjunctivitis. This study was conducted to investigate the effect of tryptase on the proliferation of conjunctival fibroblasts and studied whether this effect was mediated by protease-activated receptor (PAR)-2. METHODS. Conjunctival fibroblasts were cultured with or without tryptase (0.1 ng/mL to 1.0 μg/mL), and the proliferation rate was assessed after 48 hours. The effects of tryptase inhibitors (leupeptin, benzamidine) and a PAR-2 agonist (SLIGKV) were examined. The existence of PAR-2 mRNA and protein in conjunctival fibroblasts was examined by RT-PCR and Western blot analysis, respectively. The existence of PAR-2 in cultured conjunctival fibroblasts and conjunctival papillae from patients with vernal keratoconjunctivitis, as well as conjunctival tissue from normal subjects was examined by immunohistochemistry. RESULTS. Conjunctival fibroblast proliferation was upregulated by tryptase in a dose-dependent manner (P < 0.001). Leupeptin and benzamidine inhibited tryptase-induced fibroblast proliferation (P < 0.05), and SLIGKV mimicked tryptase's effect. PAR-2 mRNA and protein were detected in cultured conjunctival fibroblasts using RT-PCR and Western blot analysis. PAR-2 immunoreactivity in both the cultured conjunctival fibroblasts and in stromal cells in excised conjunctival tissues was observed. CONCLUSIONS. Tryptase increased conjunctival fibroblast proliferation and this response appeared to be mediated by PAR-2. Mast cells are the most likely source of tryptase in the conjunctiva and may play an important role in chronic exacerbations with conjunctival papillary formation in allergic conjunctivitis.

AB - PURPOSE. Tryptase that is released by mast cell degranulation has recently been thought to play a key role in wound healing in allergic bronchitis. Conjunctival fibroblasts secrete mediators and extracellular matrices that could exacerbate inflammation and papillary formation in allergic conjunctivitis. This study was conducted to investigate the effect of tryptase on the proliferation of conjunctival fibroblasts and studied whether this effect was mediated by protease-activated receptor (PAR)-2. METHODS. Conjunctival fibroblasts were cultured with or without tryptase (0.1 ng/mL to 1.0 μg/mL), and the proliferation rate was assessed after 48 hours. The effects of tryptase inhibitors (leupeptin, benzamidine) and a PAR-2 agonist (SLIGKV) were examined. The existence of PAR-2 mRNA and protein in conjunctival fibroblasts was examined by RT-PCR and Western blot analysis, respectively. The existence of PAR-2 in cultured conjunctival fibroblasts and conjunctival papillae from patients with vernal keratoconjunctivitis, as well as conjunctival tissue from normal subjects was examined by immunohistochemistry. RESULTS. Conjunctival fibroblast proliferation was upregulated by tryptase in a dose-dependent manner (P < 0.001). Leupeptin and benzamidine inhibited tryptase-induced fibroblast proliferation (P < 0.05), and SLIGKV mimicked tryptase's effect. PAR-2 mRNA and protein were detected in cultured conjunctival fibroblasts using RT-PCR and Western blot analysis. PAR-2 immunoreactivity in both the cultured conjunctival fibroblasts and in stromal cells in excised conjunctival tissues was observed. CONCLUSIONS. Tryptase increased conjunctival fibroblast proliferation and this response appeared to be mediated by PAR-2. Mast cells are the most likely source of tryptase in the conjunctiva and may play an important role in chronic exacerbations with conjunctival papillary formation in allergic conjunctivitis.

UR - http://www.scopus.com/inward/record.url?scp=33644789269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644789269&partnerID=8YFLogxK

U2 - 10.1167/iovs.05-0388

DO - 10.1167/iovs.05-0388

M3 - Article

VL - 46

SP - 4622

EP - 4626

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 12

ER -